ApprovalTrail

Drug · DIN 02438623

SIVEXTRO

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since December 15, 2023.
Drug Identification Number (DIN)
02438623
Company (DIN owner)
Merck Canada IncKirkland, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Tedizolid J01XX11
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
TEDIZOLID PHOSPHATE200 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named SIVEXTRO